Table 1 Potential factors associated with weight gain in patients following RAI treatment of GD
From: Change in BMI after radioactive iodine ablation for graves disease
Variable – Mean ± SD Median (range) | Whole population (n = 157) | Sub-analysis (n = 81) | ||||
|---|---|---|---|---|---|---|
Age | 12.68 ± 3.00 y | 12.79 ± 3.02 y | ||||
12.86 (5.34-17.89) y | 12.77 (5.34-17.83) y | |||||
∆BMI SDS | p-value | ∆BMI SDS | p-value | |||
Gender | Female (%) 0.71 ± 0.66 (79.6) | Male (%) 0.71 ± 0.92 (20.4) | 0.99 | Female (%) 0.69 ± 0.65 (85.2) | Male (%) 0.35 ± 0.47 (14.8) | 0.09 |
0.61 (−0.4-2.97) | 0.41 (−0.55-3.85) | 0.69 (−0.4-2.68) | 0.24 (−0.55-1.24) | |||
Yes (%) | No (%) | Yes (%) | No (%) | |||
ATD use | 0.64 ± 0.68 (21) | 0.73 ± 0.73 (79) | 0.55 | 0.67 ± 0.77 (18.5) | 0.63 ± 0.60 (81.5) | 0.81 |
0.46 (−0.37-2.68) | 0.54 (−0.55-3.85) | 0.55 (−0.25-2.68) | 0.66 (−0.55-2.04) | |||
Down syndrome | 0.85 ± 0.86 (6.4) | 0.70 ± 0.71 (93.6) | 0.53 | 1.04 ± 0.90 (7.4) | 0.61 ± 0.60 (92.6) | 0.10 |
0.88 (0.0-2.68) | 0.53 (−0.55-3.85) | 0.88 (0.17-2.68) | 0.59 (−0.55-2.04) | |||
ADHD treatment | 0.97 ± 1.08 (7.6) | 0.69 ± 0.68 (92.4) | 0.40 | 0.98 ± 0.79 (4.9) | 0.62 ± 0.62 (95.1) | 0.26 |
0.44 (0.08-3.85) | 0.55 (−0.55-2.97) | 0.97 (0.08-1.92) | 0.59 (−0.55-2.68) | |||
History of weight loss | 0.92 ± 0.84 (38.2) | 0.56 ± 0.57 (49) | 0.005* | 0.77 ± 0.62 (39.5) | 0.55 ± 0.56 (50.6) | 0.12 |
0.74 (−0.55-3.85) | 0.45 (−0.4-2.47) | 0.74 (−0.55-2.00) | 0.57 (−0.4-2.04) | |||
Pubertal | 0.67 ± 0.63 (56.1) | 0.91 ± 0.90 (29.9) | 0.10 | 0.57 ± 0.58 (56.8) | 0.90 ± 0.71 (29.6) | 0.04* |
0.49 (−0.4-2.71) | 0.75 (−0.37-3.85) | 0.50 (−0.4-2.04) | 0.82 (−0.35-2.68) | |||